In Brief: Dow Chemical breast implant litigation
This article was originally published in The Gray Sheet
Dow Chemical breast implant litigation: Reno, Nevada jury finds Dow Corning parent firm liable for $4.1 mil. in compensatory damages and $10 mil. in punitive damages to plaintiffs Charlotte and Marvin Mahlum for injuries ascribed to Dow Corning silicone gel breast implants. Dow Chemical says it will seek to have the verdict "set aside" on the grounds that the jury's decision was not supported by evidence. In April, federal court Judge Samuel Pointer upheld a plaintiff's motion making Dow Chemical subject to direct liability claims ("The Gray Sheet" May 1, I&W-16)...
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.